Signal Bureau What’s happening · what the record shows

Oncolytics Biotech

A topic on our watch list — we track its coverage across 2 domains, including Gi Journal and CRC Treatment.

If Oncolytics Biotech is on your watch list: what changed in the coverage, what the reporting asserts, and what the crowd is pricing.

What’s changed

Oncolytics Biotech Announces Rapid REO 033 Site Activation and FDA Meeting on Registrational Pathway for Pelareorep in Metastatic Colorectal Cancer - Quiver Qua · CRC Research (Google News) · 2026-07-13
Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial - The Globe and Mail · CRC Research (Google News) · 2026-07-13

Ask the engine about Oncolytics Biotech ＋ Track Oncolytics Biotech for a daily read

Informational only — not financial, legal, or investment advice. Prediction-market prices are shown as a signal of what the crowd believes. Terms · Privacy · page rendered Jul 28, 8:29 AM PT